Literature DB >> 25821092

Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

Marco Castori, Silvia Morlino, Giulia Pascolini, Carlo Blundo, Paola Grammatico.   

Abstract

Gastrointestinal involvement is a well known complication of Ehlers-Danlos syndromes (EDSs), mainly in form of abdominal emergencies due to intestinal/abdominal vessels rupture in vascular EDS. In the last decade, a growing number of works investigated the relationship between a wide spectrum of chronic gastrointestinal complaints and various EDS forms, among which the hypermobility type (a.k.a. joint hypermobility syndrome; JHS/EDS-HT) was the most studied. The emerging findings depict a major role for gastrointestinal involvement in the health status and, consequently, management of JHS/EDS-HT patients. Nevertheless, fragmentation of knowledge limits its impact on practice within the boundaries of highly specialized clinics. In this paper, literature review on gastrointestinal manifestations in JHS/EDS-HT was carried out and identified papers categorized as (i) case-control/cohort studies associating (apparently non-syndromic) joint hypermobility and gastrointestinal involvement, (ii) case-control/cohort studies associating JHS/EDS-HT and gastrointestinal involvement, (iii) case reports/series on various gastrointestinal complications in (presumed) JHS/EDS-HT, and (iv) studies reporting gastrointestinal features in heterogeneous EDS patients' cohorts. Gastrointestinal manifestations of JHS/EDS-HT were organized and discussed in two categories, including structural anomalies (i.e., abdominal/diaphragmatic hernias, internal organ/pelvic prolapses, intestinal intussusceptions) and functional features (i.e., dysphagia, gastro-esophageal reflux, dyspepsia, recurrent abdominal pain, constipation/diarrhea), with emphasis on practice and future implications. In the second part of this paper, a summary of possible nutritional interventions in JHS/EDS-HT was presented. Supplementation strategies were borrowed from data available for general population with minor modifications in the light of recent discoveries in the pathogenesis of selected JHS/EDS-HT features.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos syndrome; abdominal pain; constipation; diet; nutraceuticals

Mesh:

Year:  2015        PMID: 25821092     DOI: 10.1002/ajmg.c.31431

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  19 in total

1.  The Prevalence of Hypermobility in Children with Irritable Bowel Syndrome and Functional Abdominal Pain Is Similar to that in Healthy Children.

Authors:  Robert J Shulman; Mariella M Self; Danita I Czyzewski; Jerry Goldberg; Margaret Heitkemper
Journal:  J Pediatr       Date:  2020-05-04       Impact factor: 4.406

2.  Visceroptosis and the Ehlers-Danlos Syndrome.

Authors:  Stephen Kucera; Stephen N Sullivan
Journal:  Cureus       Date:  2017-11-08

Review 3.  Difficulty eating and significant weight loss in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

Authors:  Carolina Baeza-Velasco; Thomas Van den Bossche; Daniel Grossin; Claude Hamonet
Journal:  Eat Weight Disord       Date:  2015-10-27       Impact factor: 4.652

4.  Gastrointestinal and eating problems in women with Ehlers-Danlos syndromes.

Authors:  Carolina Baeza-Velasco; Sonia Lorente; Elisabet Tasa-Vinyals; Sébastien Guillaume; Maria Soledad Mora; Paola Espinoza
Journal:  Eat Weight Disord       Date:  2021-02-13       Impact factor: 4.652

5.  Clinical Characterization of Pediatric Gastroparesis Using a Four-hour Gastric Emptying Scintigraphy Standard.

Authors:  Sharon Wolfson; Zoe Wilhelm; Antone R Opekun; Robert Orth; Robert J Shulman; Bruno P Chumpitazi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-06-01       Impact factor: 3.288

6.  Ehlers-Danlos syndrome hypermobility type is associated with rheumatic diseases.

Authors:  Kyla R Rodgers; Jiang Gui; Mary Beth P Dinulos; Richard C Chou
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

7.  Transcriptome-Wide Expression Profiling in Skin Fibroblasts of Patients with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome Hypermobility Type.

Authors:  Nicola Chiarelli; Giulia Carini; Nicoletta Zoppi; Chiara Dordoni; Marco Ritelli; Marina Venturini; Marco Castori; Marina Colombi
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

8.  A humanisation approach for the management of Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-Hypermobility Type (JHS/EDS-HT).

Authors:  Carol J Clark; Isobel Knight
Journal:  Int J Qual Stud Health Well-being       Date:  2017-12

9.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

10.  Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience.

Authors:  Mohammad Alomari; Asif Hitawala; Pravallika Chadalavada; Fahrettin Covut; Laith Al Momani; Shrouq Khazaaleh; Falgun Gosai; Suleiman Al Ashi; Ashraf Abushahin; Alison Schneider
Journal:  Cureus       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.